Appendix C: Clinical Trial Efficacy Data for Daily, Oral Tenofovir Disoproxil Fumarate/Emtricitabine as Pre-Exposure Prophylaxis

Updated
Reviewed
Dec. 24, 2019

Appendix C: Clinical Trial Efficacy Data for Daily, Oral Tenofovir Disoproxil Fumarate/Emtricitabine as Pre-Exposure Prophylaxis
   
   
   
   
 

References

  1. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399-410. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22784037.
  2. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22784038.
  3. Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411-22. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22784040.
  4. Donnell D, Baeten JM, Bumpus NN, et al. HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. J Acquir Immune Defic Syndr. 2014;66(3):340-348. Available at: https://www.ncbi.nlm.nih.gov/pubmed/24784763.

Appendix C: Clinical Trial Efficacy Data for Daily, Oral Tenofovir Disoproxil Fumarate/Emtricitabine as Pre-Exposure Prophylaxis
   
   
   
   
 

References

  1. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399-410. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22784037.
  2. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22784038.
  3. Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411-22. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22784040.
  4. Donnell D, Baeten JM, Bumpus NN, et al. HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. J Acquir Immune Defic Syndr. 2014;66(3):340-348. Available at: https://www.ncbi.nlm.nih.gov/pubmed/24784763.
Documents
Section OnlyPDF (344.46 KB)
Full GuidelinePDF (2.76 MB)
Recommendations OnlyPDF (313.35 KB)
Tables OnlyPDF (572.94 KB)

Download Guidelines